Related Experiment Videos

Doppler assessment of diastolic function in cardiac amyloidosis

A L Klein1, A J Tajik

  • 1Department of Cardiology, The Cleveland Clinic Foundation, OH 44106.

Insights

Cardiac amyloidosis causes a stiff heart due to amyloid infiltration. Doppler echocardiography effectively characterizes diastolic dysfunction, revealing abnormalities that correlate with disease severity and predict patient outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Physiology

Background:

  • Cardiac amyloidosis is characterized by amyloid infiltration of the heart, leading to abnormal diastolic function and the "stiff heart syndrome."
  • The precise nature of diastolic dysfunction in cardiac amyloidosis remains incompletely understood.

Purpose of the Study:

  • To assess left and right ventricular diastolic function in patients with cardiac amyloidosis using Doppler echocardiography.
  • To correlate Doppler-derived filling abnormalities with the extent of cardiac amyloid infiltration.
  • To evaluate the prognostic value of diastolic function parameters in cardiac amyloidosis.

Main Methods:

  • Doppler echocardiography was used to measure left and right ventricular inflow and venous flow velocities in 53 patients.
  • Left ventricular wall thickness was used as a measure of amyloid infiltration severity.
  • Patient outcomes were monitored over a 13-month follow-up period.

Main Results:

  • Doppler echocardiography revealed a spectrum of diastolic filling abnormalities.
  • Abnormalities were dependent on left ventricular wall thickness, with advanced disease (>15 mm) showing restrictive filling and early disease (<15 mm) showing abnormal relaxation or normal filling.
  • Follow-up demonstrated an evolution of Doppler patterns from abnormal relaxation to restrictive physiology.
  • Left ventricular inflow variables were significant predictors of patient outcomes.

Conclusions:

  • Doppler echocardiography is a valuable tool for characterizing diastolic dysfunction in cardiac amyloidosis.
  • Diastolic function assessment can stratify disease severity and predict outcomes in cardiac amyloidosis.
  • Understanding diastolic dysfunction progression is crucial for managing cardiac amyloidosis.

Related Concept Videos